| Ticker: DEPU | 700 Orthopaedic Drive | |
| Exchange: NASDAQ-National Market | Warsaw, Indiana 46581 | |
| Industry: Manufacturing | (219) 267-8143 |
| Type of Shares: | Common Shares | Filing Date: | 8/1/96 | |
| U.S. Shares: | 11,824,000 | Offer Date: | 11/1/96 | |
| Non-U.S. Shares: | 2,956,000 | Filing Range: | $16.50 - $18.50 | |
| Primary Shares: | 7,780,000 | Offer Price: | $17.50 | |
| Secondary Shares: | 7,000,000 | Gross Spread: | $0.92 | |
| Offering Amount: | $258,650,000 | Selling: | $0.56 | |
| Expenses: | - | Reallowance: | $0.10 | |
| Shares Out After: | - |
| Manager | Tier | Phone |
| Morgan Stanley & Co. Incorporated | Lead Manager | (212) 703-4797 |
| Bear, Stearns & Co. Inc. | Co-manager | (212) 272-2000 |
| Cowen & Company | Co-manager | (212) 495-6000 |
| Furman Selz Incorporated | Co-manager | (212) 309-8200 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 6/30/96 | 6/30/95 | 6/30/96 | ||
| Revenue: | $636.60 | $349.00 | $323.30 | Assets: | $692.60 |
| Net Income: | $94.90 | $55.60 | $51.50 | Liabilities: | $231.50 |
| EPS: | Equity: | $461.10 | |||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is one of the world's leading designers, manufacturers and distributors or orthopedic medical specialists. In the case of the company's spinal implants, neurosurgeons in both surgical and non-surgical therapy to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, trauma and sports-related injuries. The company's products cover a broad range of orthopedic needs and include primary and revision hip, primary and revision knee and shoulder implants to reconstruct damaged joints; spinal implants to facilitate fusion of elements of the spine and to correct deformities; trauma products to reconstruct small and large bone fractures; and implants, knee braces and other soft good supplies for the rehabilitation of sports-related injuries. Additionally, the company markets complementary products for the operating room. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for the expansion of the company's business through acquisitions, provided that suitable acquisition opportunities can be identified and such acquisitions can be consummated. |
©1996 IPO Data Systems, Inc. - All rights reserved.